Burke William Patrick
SEC CIK 1880493 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NVCR | NovoCure Ltd | CHRO | 66.4K | — | $651.3K | 14 | 2022-01-03 | 2023-06-30 |
Most active insiders at NVCR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DOYLE WILLIAM F | Executive COB, Dir | — | $933.1K |
| 2 | Leonard Frank X | EVP, Pres, Novocure Oncology | — | $919.8K |
| 3 | Paravasthu Mukund | COO | — | $693.8K |
| 4 | Weinberg Uri | Chf Medical, Innovation Ofr | — | $232.2K |
| 5 | Brackmann Christoph | CFO | — | $85.3K |
| 6 | Stafford Kristin | Dir | — | $46.4K |
| 7 | Ocean Allyson J | Dir | — | $46.4K |
| 8 | Scannell Timothy J | Dir | — | $46.4K |
| 9 | VERNON W ANTHONY | Dir | — | $46.4K |
| 10 | Hung David | Dir | — | $46.4K |
Burke William Patrick made no open-market trades at NVCR in the last 12 months.
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-06 | 2023-06-30 | NVCR | NovoCure Ltd | Burke William Patrick | CHRO | A - Grant | $35.28 | +357 | 66.4K | +0.5% | +$12.6K | |
| 2023-03-07 | 2023-03-03 | NVCR | NovoCure Ltd | Burke William Patrick | CHRO | S - Sale | $76.16 | -593 | 66.1K | -0.9% | -$45.2K | |
| 2023-03-06 | 2023-03-02 | NVCR | NovoCure Ltd | Burke William Patrick | CHRO | S - Sale | $75.28 | -281 | 66.7K | -0.4% | -$21.2K | |
| D | 2023-03-02 | 2023-02-28 | NVCR | NovoCure Ltd | Burke William Patrick | CHRO | A - Grant | $0.00 | +12.1K | 67.7K | +22% | $0 |
| D | 2023-03-02 | 2023-03-01 | NVCR | NovoCure Ltd | Burke William Patrick | CHRO | S - Sale | $76.36 | -755 | 67.0K | -1% | -$57.7K |
| 2023-01-10 | 2023-01-06 | NVCR | NovoCure Ltd | Burke William Patrick | CHRO | A - Grant | $62.31 | +108 | 55.6K | +0.2% | +$6,729 | |
| 2022-09-06 | 2022-09-02 | NVCR | NovoCure Ltd | Burke William Patrick | CHRO | S - Sale | $79.04 | -718 | 55.5K | -1% | -$56.8K | |
| 2022-07-07 | 2022-07-05 | NVCR | NovoCure Ltd | Burke William Patrick | CHRO | A - Grant | $59.08 | +213 | 56.2K | +0.4% | +$12.6K | |
| 2022-03-09 | 2022-03-08 | NVCR | NovoCure Ltd | Burke William Patrick | CHRO | S - Sale | $70.10 | -1,037 | 56.0K | -2% | -$72.7K | |
| DM | 2022-03-07 | 2022-03-03+ | NVCR | NovoCure Ltd | Burke William Patrick | CHRO | S - Sale | $71.43 | -1,367 | 58.1K | -2% | -$97.6K |
| D | 2022-03-07 | 2022-03-03 | NVCR | NovoCure Ltd | Burke William Patrick | CHRO | A - Grant | $0.00 | +7,445 | 58.4K | +15% | $0 |
| 2022-01-12 | 2022-01-06 | NVCR | NovoCure Ltd | Burke William Patrick | CHRO | A - Grant | $63.82 | +80 | 51.0K | +0.2% | +$5,106 | |
| DM | 2022-01-05 | 2022-01-03 | NVCR | NovoCure Ltd | Burke William Patrick | CHRO | S - Sale+OE | $76.00 | -3,951 | 41.0K | -9% | -$300.3K |
| DM | 2022-01-05 | 2022-01-03 | NVCR | NovoCure Ltd | Burke William Patrick | CHRO | M - OptEx | $10.49 | +28.6K | 43.7K | +190% | +$300.0K |
Purchase Sale Sale after option exercise All abbreviations